• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

“点-线-面-体”四维钬激光前列腺剜除术治疗良性前列腺增生症的临床研究

[Clinical study of "point-line-surface-volume" four dimensional holmium laser enucleation of prostate for benign prostatic hyperplasia].

作者信息

Hao Y C, Xiao C L, Lu J, Liu K, Liu Y Q, Ma L L

机构信息

Department of Urology, Peking University Third Hospital, Beijing 100191, China.

出版信息

Zhonghua Wai Ke Za Zhi. 2019 Mar 1;57(3):194-199. doi: 10.3760/cma.j.issn.0529-5815.2019.03.007.

DOI:10.3760/cma.j.issn.0529-5815.2019.03.007
PMID:30861648
Abstract

To investigate application value of "point-line-surface-volume" four dimensional holmium laser enucleation of prostate (HoLEP) in the treatment of benign prostatic hyperplasia (BPH). From December 2016 to November 2017, the clinical data of 60 cases of BPH with the treatment of "Point-line-surface-volume" four dimensional HoLEP at Department of Urology, Peking University Third Hospital were analyzed retrospectively. The age was (73.8±8.0) years (range: 60 to 96 years), body mass index was (23.2±3.6) kg/m(2) (range: 14.9 to 31.1 kg/m(2)), volume of prostate was (64.5±36.9) ml (range: 15.5 to 197.9 ml). All the cases were operated by the same chief surgeon expert in endoscopic surgery. First of all, taking verumontanum as the anchor point, crossing point between the outer 45° line of verumontanum and middle line of the lateral lobe and verumontanum was made as the breakthrough point. The "blasting and paddling" method was used to find prostatic surgery capsule, and the two sides of the capsule plane were connected in front of the verumontanum. Secondly, the plane was maintained by the "fan tunnel" method, and the middle lobe and the lateral lobes were divided at the 5 o'clock and 7 o'clock positions. The glands of the middle lobe were first removed and pushed into the bladder. Then, on the anteroinferior inclined coronal plane through 12 o'clock point right above of verumontanum, the urethral mucosa was cut apart in a semi-curved shape in advance. Bilateral semi-curved incision confluenced above the verumontanum, and extend to the bladder neck to form an inverted Y-shaped groove which completely divided the bilateral lobes. Finally, the bilateral lobes were enucleated respectively, and glands in the bladder were removed by tissue morcellator. Clinical data included operative time, hemoglobin decrease, catheterization duration, postoperative hospital stay, preoperative and postoperative international prostate symptom score and quality of life (QOL) score. The efficiency of enucleation was calculated as prostatic volume divided by enucleation time (not including morcellation time). The efficiency of morcellation was calculated as prostatic volume divided by morcellation time. Paired -test was used to compare the indexes before and after surgery. All the operations of 60 cases were sumlessful, one of which prostate tissue was removed by conversion to transurethral resection prostate due to malfunction of tissue morcellator. The operative time was (115.2±52.9) minutes (range: 25 to 276 minutes). The enucleation efficiency was (0.81±0.35) ml/minutes (range: 0.17 to 1.58 ml/minutes). The morcellation efficiency was (6.60±4.28) ml/minutes (range: 0.89 to 17.42 ml/minutes). The hemoglobin was decreased by (15.9±12.3) g/L (range:-10 to 57 g/L). Meanwhile, catheterization duration was (5.2±2.9) days (range: 0.8 to 19.8 days), and postoperative hospital stays were (5.0±1.5) days (range: 1.9 to 11.9 days). Preoperative and postoperative IPSS scores (10.92±6.98 . 23.37±7.49, 10.357, 0.000) and QOL scores (1.75±1.62 . 4.53±1.47, 9.373, 0.000) were significantly different. Postoperative complications included: 4 cases of fever (greater than 38.5 ℃), 1 case of acute epididymitis, 1 case of bladder mucosal injury, and 1 case of active bleeding need blood transfusion therapy. "Point-line-surface-volume" four dimensional HoLEP is an effective and safe minimally invasive method in the treatment of BPH.

摘要

探讨“点-线-面-体”四维钬激光前列腺剜除术(HoLEP)治疗良性前列腺增生(BPH)的应用价值。回顾性分析2016年12月至2017年11月在北京大学第三医院泌尿外科采用“点-线-面-体”四维HoLEP治疗的60例BPH患者的临床资料。患者年龄为(73.8±8.0)岁(范围:60至96岁),体重指数为(23.2±3.6)kg/m²(范围:14.9至31.1 kg/m²),前列腺体积为(64.5±36.9)ml(范围:15.5至197.9 ml)。所有病例均由同一位内镜手术首席专家主刀。首先,以精阜为锚点,精阜外侧45°线与中叶中线及精阜的交点作为突破点。采用“爆破与划动”法寻找前列腺外科包膜,并在精阜前方连接包膜平面两侧。其次,采用“扇形隧道”法维持平面,在5点和7点位置将中叶和侧叶分开。先切除中叶腺体并将其推入膀胱。然后,在精阜正上方12点处的前下斜冠状面上,预先将尿道黏膜呈半弧形切开。双侧半弧形切口在精阜上方汇合,并延伸至膀胱颈形成倒Y形沟,将双侧叶完全分开。最后,分别剜除双侧叶,并通过组织粉碎器清除膀胱内腺体。临床资料包括手术时间、血红蛋白下降情况、导尿时间、术后住院时间、术前及术后国际前列腺症状评分和生活质量(QOL)评分。剜除效率计算为前列腺体积除以剜除时间(不包括粉碎时间)。粉碎效率计算为前列腺体积除以粉碎时间。采用配对t检验比较手术前后各项指标。60例手术均成功,其中1例因组织粉碎器故障改行经尿道前列腺切除术切除前列腺组织。手术时间为(115.2±52.9)分钟(范围:25至276分钟)。剜除效率为(0.81±0.35)ml/分钟(范围:0.17至1.58 ml/分钟)。粉碎效率为(6.60±4.28)ml/分钟(范围:0.89至17.42 ml/分钟)。血红蛋白下降(15.9±12.3)g/L(范围:-10至57 g/L)。同时,导尿时间为(5.2±2.9)天(范围:0.8至19.8天),术后住院时间为(5.0±1.5)天(范围:1.9至11.9天)。术前及术后国际前列腺症状评分(10.92±6.98、23.37±7.49,t = 10.357,P = 0.000)和生活质量评分(1.75±1.62、4.53±1.47,t = 9.373,P = 0.000)差异有统计学意义。术后并发症包括:4例发热(体温大于38.℃),1例急性附睾炎,1例膀胱黏膜损伤,1例活动性出血需输血治疗。“点-线-面-体”四维HoLEP是治疗BPH有效且安全的微创方法。

相似文献

1
[Clinical study of "point-line-surface-volume" four dimensional holmium laser enucleation of prostate for benign prostatic hyperplasia].“点-线-面-体”四维钬激光前列腺剜除术治疗良性前列腺增生症的临床研究
Zhonghua Wai Ke Za Zhi. 2019 Mar 1;57(3):194-199. doi: 10.3760/cma.j.issn.0529-5815.2019.03.007.
2
[Low power seven-step two-lobe holmium laser enucleation of the prostate technique for surgical treatment of benign prostatic hyperplasia].[低功率七步法双叶钬激光前列腺剜除术治疗良性前列腺增生症的手术技术]
Beijing Da Xue Xue Bao Yi Xue Ban. 2019 Dec 18;51(6):1159-1164. doi: 10.19723/j.issn.1671-167X.2019.06.032.
3
Feasibility of holmium laser enucleation of the prostate (HoLEP) for recurrent/residual benign prostatic hyperplasia (BPH).钬激光前列腺剜除术(HoLEP)治疗复发性/残留良性前列腺增生(BPH)的可行性。
BJU Int. 2012 Dec;110(11 Pt C):E845-50. doi: 10.1111/j.1464-410X.2012.11290.x. Epub 2012 Jun 15.
4
A randomized trial comparing holmium laser enucleation of the prostate with transurethral resection of the prostate for the treatment of bladder outlet obstruction secondary to benign prostatic hyperplasia in large glands (40 to 200 grams).一项随机试验,比较钬激光前列腺剜除术与经尿道前列腺切除术治疗大腺体(40至200克)良性前列腺增生继发膀胱出口梗阻的疗效。
J Urol. 2003 Oct;170(4 Pt 1):1270-4. doi: 10.1097/01.ju.0000086948.55973.00.
5
[Monoplane versu biplane holmium laser enucleation of the prostate for the treatment of large-volume benign prostatic hyperplasia].[单平面与双平面钬激光前列腺剜除术治疗大体积良性前列腺增生症]
Zhonghua Nan Ke Xue. 2020 Mar;26(3):242-249.
6
Bipolar plasma enucleation of the prostate vs open prostatectomy in large benign prostatic hyperplasia cases - a medium term, prospective, randomized comparison.经尿道双极等离子前列腺剜除术与开放性前列腺切除术治疗大体积良性前列腺增生症的中期前瞻性随机对照研究。
BJU Int. 2013 May;111(5):793-803. doi: 10.1111/j.1464-410X.2012.11730.x. Epub 2013 Mar 7.
7
Holmium Laser Enucleation Versus Bipolar Plasmakinetic Resection for Management of Lower Urinary Tract Symptoms in Patients with Large-Volume Benign Prostatic Hyperplasia: Randomized-Controlled Trial.钬激光前列腺剜除术与双极等离子前列腺剜除术治疗大体积良性前列腺增生患者下尿路症状的随机对照研究。
J Endourol. 2021 Feb;35(2):171-179. doi: 10.1089/end.2020.0636. Epub 2020 Oct 29.
8
Anatomical Control of Adenoma Technique: An Accurate Surgical Approach to Thulium Laser Enucleation of the Prostate.腺瘤技术的解剖学控制:一种准确的前列腺铥激光剜除术手术方法。
Urology. 2018 Mar;113:252. doi: 10.1016/j.urology.2017.11.037. Epub 2017 Dec 7.
9
Holmium:YAG transurethral incision versus laser photoselective vaporization for benign prostatic hyperplasia in a small prostate.钬激光经尿道前列腺切开术与激光光选择性汽化术治疗小前列腺良性前列腺增生的比较。
J Urol. 2014 Jan;191(1):148-54. doi: 10.1016/j.juro.2013.06.113. Epub 2013 Jul 8.
10
Holmium laser enucleation of the prostate combined with mechanical morcellation in 155 patients with benign prostatic hyperplasia.钬激光前列腺剜除术联合机械粉碎术治疗155例良性前列腺增生患者
Urology. 2002 Sep;60(3):449-53. doi: 10.1016/s0090-4295(02)01812-5.